Sterling Pharma Solutions has announced that the expansion of its pilot plant facility in the UK is now operational, following a £6m ($8m) investment last year. The new facility – which includes three new reactor trains at scales of 225l, 500l and 1,360l – “increases the existing pilot plant’s capacity by 33%, enhancing the contract development and manufacturing organization’s (CDMO’s) scale-up capabilities and adding greater flexibility to cater for small to mid-scale clinical supply and commercial batch production,” Sterling commented.
Kevin Cook, Sterling’s CEO, said the ability to cater for smaller volumes would be “essential as we move forward,” due...




